Fig. 1. Serum concentration–time curve (mean ± standard deviation; n = 16) of etonogestrel and ethinylestradiol during treatment with NuvaRing (days 1 to 21 [intended use] and days 22 to 35 [extended use]). (Timmer. Clin Pharmacokinet 39:233–242, 2000.)